Article
De-novo purine biosynthesis is a major driver of chemoresistance in glioblastoma
medRxiv · 2020 · Jack M Shireman
Key facts
| Title | De-novo purine biosynthesis is a major driver of chemoresistance in glioblastoma |
|---|---|
| First author | Jack M Shireman |
| Journal | medRxiv |
| Published | Mar 16, 2020 |
| DOI | 10.1101/2020.03.13.991125 |
| Devices mentioned | K152294, K233719, K802418 |
| Product codes mentioned | DOP, IZL, JCC, JJH, KPA, KPR, MQB, NJT, PFT, PPM, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1